Trevi Therapeutics Inc (TRVI) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access TRVI Annual Balance Sheets →
The data below summarizes Trevi Therapeutics Inc's balance sheet position from Jun 30 2025 to Jun 30 2026, enabling a period-by-period comparison of financial strength.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent54.30
Marketable Securities, Current SH264.57
Cash & Short-term Investments318.00
Other Current Assets2.57
Prepaid Expense, Current AS4.26
Total Current Assets325.71
Equipment/Property/Plant Net0.34
Other Assets, Noncurrent4.48
Operating Lease Right Of Use Asset0.61
Total Assets330.52
Liabilities
Accounts Payable, Current AC3.10
Accrued Liabilities, Current AC5.31
Other Liabilities, Current0.33
Total Current Liabilities8.74
Total Long-term Debt0.00
Other liabilities, Noncurrent0.28
Operating Lease Liability Current0.32
Operating Lease Liability Noncurrent0.36
Total Liabilities9.01
Stockholders' Equity
Common Stock Value0.14
Additional Paid In Capital Common Stock682.58
Retained Earnings / Accumulated Deficit-360.79
Accumulated Other Comprehensive Income-0.43
Other Equity-0.43
Common Stockholder's Equity321.51
Total Stockholder's Equity321.51
Liabilities & Stockholder's Equity330.52
4 historic quarters locked

Sign in to unlock the full Trevi Therapeutics Inc balance sheet history.

About Trevi Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-338023

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.